…
Bright Green Corporation produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products are used in research, manufacturing, and export, as well as for production of medical cannabis products and preparations. The company was incorporated in 2019 and is based in Grants, New Mexico.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -27.53M | -2.49M | -3.05M | - |
| Net income | -28.09M | -2.49M | -3.16M | - |
| Selling general administrative | 26.32M | 1.74M | 2.11M | - |
| Gross profit | 0.20M | - | - | - |
| Reconciled depreciation | 0.70M | 0.75M | 0.84M | - |
| Ebit | -27.31M | -2.49M | -2.85M | -1.31M |
| Ebitda | -26.40M | -1.74M | -2.01M | - |
| Depreciation and amortization | 0.92M | 0.75M | 0.84M | - |
| Operating income | -27.31M | -2.49M | -2.85M | - |
| Other operating expenses | 27.31M | 2.49M | 2.95M | 0.07M |
| Interest expense | 0.21M | 0.00M | 0.00M | 0.00M |
| Tax provision | 0.00M | 0.00M | 0.00M | - |
| Income tax expense | 0.56M | - | 0.10M | - |
| Total revenue | 0.20M | 0.00M | 0.00M | - |
| Total operating expenses | 27.31M | 2.49M | 2.95M | - |
| Total other income expense net | -0.21M | - | -0.21M | - |
| Net income from continuing ops | -27.53M | -2.49M | -3.05M | - |
| Net income applicable to common shares | -27.66M | -2.49M | -3.05M | -1.31M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 17.40M | 22.79M | 8.78M | 7.90M | - |
| Intangible assets | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Other current assets | 0.26M | 0.08M | 0.17M | 0.02M | 0.06M |
| Total liab | 6.44M | 11.21M | 0.56M | 0.68M | - |
| Total stockholder equity | 10.96M | 11.58M | 8.22M | 7.22M | - |
| Other current liab | 0.41M | 0.45M | 0.02M | 0.12M | - |
| Common stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M |
| Capital stock | 0.02M | 0.02M | 0.02M | 0.02M | - |
| Retained earnings | -47.20M | -34.08M | -6.41M | -3.92M | -0.87M |
| Other assets | - | 1.16M | - | - | - |
| Cash | 0.01M | 0.41M | 1.28M | 0.10M | - |
| Total current liabilities | 6.24M | 7.52M | 0.17M | 0.30M | 0.17M |
| Net debt | 1.84M | 5.31M | -0.89M | 0.28M | - |
| Short term debt | 1.65M | 2.04M | - | - | - |
| Short long term debt | 1.65M | 2.04M | - | - | - |
| Short long term debt total | 1.85M | 5.73M | 0.39M | 0.38M | - |
| Other stockholder equity | 58.15M | 45.64M | 14.62M | 11.13M | - |
| Property plant equipment | - | 17.15M | 7.33M | 7.78M | 8.60M |
| Total current assets | 0.27M | 0.49M | 1.45M | 0.12M | 0.06M |
| Long term investments | 0.73M | 3.99M | - | - | - |
| Net tangible assets | - | 11.58M | 8.22M | 7.22M | 8.49M |
| Long term debt | 0.20M | 3.69M | 0.39M | 0.38M | - |
| Accounts payable | 4.18M | 5.03M | 0.15M | 0.18M | 0.08M |
| Common stock total equity | - | 0.02M | - | - | - |
| Retained earnings total equity | - | -34.08M | - | - | - |
| Non currrent assets other | - | 1.16M | - | - | - |
| Non current assets total | 17.13M | 22.30M | 7.33M | 7.78M | - |
| Long term debt total | - | 3.69M | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -14.37M | -0.30M | -2.69M | -2.69M |
| Change to liabilities | 5.31M | -0.03M | 0.10M | 0.12M |
| Total cashflows from investing activities | -14.37M | -0.30M | -0.30M | -0.30M |
| Net borrowings | 3.58M | 0.01M | 0.38M | 0.38M |
| Total cash from financing activities | 15.77M | 3.14M | 0.62M | 0.30M |
| Change to operating activities | 0.63M | -0.25M | 0.07M | 0.05M |
| Net income | -27.66M | -2.49M | -3.05M | -1.31M |
| Change in cash | -0.87M | 1.18M | 0.10M | 0.10M |
| Begin period cash flow | 1.28M | 0.10M | 0.00M | - |
| End period cash flow | 0.41M | 1.28M | 0.10M | - |
| Total cash from operating activities | -2.27M | -1.66M | -0.51M | -0.30M |
| Issuance of capital stock | 12.19M | 3.13M | 0.23M | - |
| Depreciation | 0.70M | 0.75M | 0.84M | 0.79M |
| Other cashflows from investing activities | -1.16M | -1.16M | -1.16M | -1.16M |
| Sale purchase of stock | 12.19M | - | - | - |
| Other cashflows from financing activities | 5.19M | 0.01M | 0.38M | - |
| Change to netincome | 18.83M | 0.36M | 1.54M | 0.04M |
| Capital expenditures | 11.68M | 0.30M | 0.30M | 0.30M |
| Change receivables | 0.11M | - | - | - |
| Cash flows other operating | 0.44M | - | - | - |
| Cash and cash equivalents changes | -0.87M | - | - | - |
| Change in working capital | 5.51M | -0.28M | 0.16M | - |
| Stock based compensation | 18.83M | 0.36M | 1.43M | - |
| Other non cash items | 0.35M | - | 0.10M | - |
| Free cash flow | -13.95M | -1.96M | -0.51M | - |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| MKKGY Merck KGaA ADR |
-0.01 0.03% |
33.66 | 21.25 | 14.93 | 3.10 | 2.14 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
0.04 0.02% |
169.25 | 24.86 | 15.11 | 3.13 | 1.98 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.90 4.50% |
20.91 | - | 10.96 | 0.01 | 1.20 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
4.03 10.61% |
42.00 | - | 10.66 | 0.01 | 1.16 | 23.11 |
Bright Green Corporation produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products are used in research, manufacturing, and export, as well as for production of medical cannabis products and preparations. The company was incorporated in 2019 and is based in Grants, New Mexico.
1033 George Hanosh Boulevard, Grants, NM, United States, 87020
833 658 1799
5
| Name | Title | Year Born |
|---|---|---|
| Mr. Terry Rafih | CEO & Exec. Chairman | 1956 |
| Mr. Saleem Elmasri | Chief Financial Officer | 1986 |
| Ms. Lynn Stockwell | Co-Founder & Chair of the Board | 1958 |
| Mr. Saleem Elmasri CPA | Chief Financial Officer | 1987 |
| Mr. Gurvinder Singh | CEO & Director | 1978 |
| Ms. Lynn Stockwell | Co-Founder & Chair of the Board | 1957 |
| Mr. Gurvinder Singh | CEO & Director | 1977 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.